Y
Yolanda I. Garces
Researcher at Mayo Clinic
Publications - 163
Citations - 7322
Yolanda I. Garces is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Lung cancer & Radiation therapy. The author has an hindex of 43, co-authored 157 publications receiving 6100 citations. Previous affiliations of Yolanda I. Garces include University of Rochester & Carleton University.
Papers
More filters
Journal ArticleDOI
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D. Bradley,Rebecca Paulus,Ritsuko Komaki,Gregory A. Masters,George R. Blumenschein,Steven E. Schild,Jeffrey A. Bogart,Chen Hu,Kenneth M. Forster,Anthony M. Magliocco,V.S. Kavadi,Yolanda I. Garces,Samir Narayan,Puneeth Iyengar,Cliff G. Robinson,Raymond B. Wynn,Christopher Koprowski,Joanne Meng,Jonathan J. Beitler,Rakesh Gaur,Walter J. Curran,Hak Choy +21 more
TL;DR: Overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the addition of cetuximab to concurrent chemoradiation for patients with inoperable stage III non-small-cell lung cancer was compared.
Journal ArticleDOI
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.
Andrea Bezjak,Rebecca Paulus,Laurie E. Gaspar,Robert Timmerman,William L. Straube,William F. Ryan,Yolanda I. Garces,Anthony T. Pu,Anurag K. Singh,Gregory M.M. Videtic,Ronald C. McGarry,Puneeth Iyengar,Jason Pantarotto,James J. Urbanic,Alexander Y. Sun,Megan E. Daly,Inga S. Grills,Paul W. Sperduto,Daniel P. Normolle,Jeffrey D. Bradley,Hak Choy +20 more
TL;DR: Outcomes in this medically inoperable group of mostly elderly patients with comorbidities were comparable with that of patients with peripheral early-stage tumors, and the MTD for this study was 12.0 Gy/fx; it was associated with 7.2% DLTs and high rates of tumor control.
Journal ArticleDOI
Primary analysis of a phase II randomized trial radiation therapy Oncology Group (RTOG) 0212: Impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer
Aaron H. Wolfson,Kyounghwa Bae,Ritsuko Komaki,Christina A. Meyers,Benjamin Movsas,Cécile Le Péchoux,Maria Werner-Wasik,Gregory M.M. Videtic,Yolanda I. Garces,Hak Choy +9 more
TL;DR: Because of the increased risk of developing CNt in study patients with 36 Gy, a total PCI dose of 25 Gy remains the standard of care for patients with LD SCLC attaining a complete response to initial chemoradiation.
Journal ArticleDOI
The relationship between cigarette smoking and quality of life after lung cancer diagnosis.
Yolanda I. Garces,Ping Yang,Julia Parkinson,Xinghua Zhao,Jason A. Wampfler,Jon O. Ebbert,Jeff A. Sloan +6 more
TL;DR: It is suggested that persistent cigarette smoking after a lung cancer diagnosis negatively impacts QOL scores, and the hypothesized relationship between smoking status and QOL was supported by this correlational study.
Journal ArticleDOI
Stereotactic radiosurgery for cavernous malformations.
Bruce E. Pollock,Yolanda I. Garces,Scott L. Stafford,Robert L. Foote,Paula J. Schomberg,Michael J. Link +5 more
TL;DR: It is impossible to conclude that radiosurgery protects patients with CMs against future hemorrhage risk based on the available data, although it appears that some reduction in the bleeding rate occurs after a latency interval of several years.